Home Pharmaceuticals Narcolepsy Therapeutics Market Size to Grow at a CAGR of 8.2% by 2031

Narcolepsy Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), By Product (Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, Others), By Region (North America, Asia-Pacific, Europe, The Middle East and Africa, Latin America) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2031

Report Code: SRPH55922DR
Last Updated : 26,Feb 2024
Author : Straits Research
Starting From
USD 995
Buy Now
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Narcolepsy Therapeutics Market, By Treatment (2019-2031)
    1. Narcolepsy with Cataplexy
    2. Narcolepsy without Cataplexy
    3. Secondary Narcolepsy
  2. Narcolepsy Therapeutics Market, By Product (2019-2031)
    1. Central Nervous System Stimulants
    2. Sodium Oxybate
    3. Selective Serotonin Reuptake Inhibitor
    4. Tricyclic Antidepressants
    5. Others
  3. Narcolepsy Therapeutics Market, By Region (2019-2031)
    1. North America
    2. Asia-Pacific
    3. Europe
    4. The Middle East and Africa
    5. Latin America
    1. North America
      1. North America Narcolepsy Therapeutics Market, By Treatment
        1. Narcolepsy with Cataplexy
          1. Narcolepsy without Cataplexy
            1. Secondary Narcolepsy
            2. North America Narcolepsy Therapeutics Market, By Product
              1. Central Nervous System Stimulants
                1. Sodium Oxybate
                  1. Selective Serotonin Reuptake Inhibitor
                    1. Tricyclic Antidepressants
                      1. Others
                      2. North America Narcolepsy Therapeutics Market, By Region
                        1. North America
                          1. Asia-Pacific
                            1. Europe
                              1. The Middle East and Africa
                                1. Latin America
                                2. U.S.
                                  1. U.S. Narcolepsy Therapeutics Market, By Treatment
                                    1. Narcolepsy with Cataplexy
                                      1. Narcolepsy without Cataplexy
                                        1. Secondary Narcolepsy
                                        2. U.S. Narcolepsy Therapeutics Market, By Product
                                          1. Central Nervous System Stimulants
                                            1. Sodium Oxybate
                                              1. Selective Serotonin Reuptake Inhibitor
                                                1. Tricyclic Antidepressants
                                                  1. Others
                                                  2. U.S. Narcolepsy Therapeutics Market, By Region
                                                    1. North America
                                                      1. Asia-Pacific
                                                        1. Europe
                                                          1. The Middle East and Africa
                                                            1. Latin America
                                                          2. Canada
                                                        2. Europe
                                                          1. Europe Narcolepsy Therapeutics Market, By Treatment
                                                            1. Narcolepsy with Cataplexy
                                                              1. Narcolepsy without Cataplexy
                                                                1. Secondary Narcolepsy
                                                                2. Europe Narcolepsy Therapeutics Market, By Product
                                                                  1. Central Nervous System Stimulants
                                                                    1. Sodium Oxybate
                                                                      1. Selective Serotonin Reuptake Inhibitor
                                                                        1. Tricyclic Antidepressants
                                                                          1. Others
                                                                          2. Europe Narcolepsy Therapeutics Market, By Region
                                                                            1. North America
                                                                              1. Asia-Pacific
                                                                                1. Europe
                                                                                  1. The Middle East and Africa
                                                                                    1. Latin America
                                                                                    2. U.K.
                                                                                      1. U.K. Narcolepsy Therapeutics Market, By Treatment
                                                                                        1. Narcolepsy with Cataplexy
                                                                                          1. Narcolepsy without Cataplexy
                                                                                            1. Secondary Narcolepsy
                                                                                            2. U.K. Narcolepsy Therapeutics Market, By Product
                                                                                              1. Central Nervous System Stimulants
                                                                                                1. Sodium Oxybate
                                                                                                  1. Selective Serotonin Reuptake Inhibitor
                                                                                                    1. Tricyclic Antidepressants
                                                                                                      1. Others
                                                                                                      2. U.K. Narcolepsy Therapeutics Market, By Region
                                                                                                        1. North America
                                                                                                          1. Asia-Pacific
                                                                                                            1. Europe
                                                                                                              1. The Middle East and Africa
                                                                                                                1. Latin America
                                                                                                              2. Germany
                                                                                                              3. France
                                                                                                              4. Spain
                                                                                                              5. Italy
                                                                                                              6. Russia
                                                                                                              7. Nordic
                                                                                                              8. Benelux
                                                                                                              9. Rest of Europe
                                                                                                            2. APAC
                                                                                                              1. APAC Narcolepsy Therapeutics Market, By Treatment
                                                                                                                1. Narcolepsy with Cataplexy
                                                                                                                  1. Narcolepsy without Cataplexy
                                                                                                                    1. Secondary Narcolepsy
                                                                                                                    2. APAC Narcolepsy Therapeutics Market, By Product
                                                                                                                      1. Central Nervous System Stimulants
                                                                                                                        1. Sodium Oxybate
                                                                                                                          1. Selective Serotonin Reuptake Inhibitor
                                                                                                                            1. Tricyclic Antidepressants
                                                                                                                              1. Others
                                                                                                                              2. APAC Narcolepsy Therapeutics Market, By Region
                                                                                                                                1. North America
                                                                                                                                  1. Asia-Pacific
                                                                                                                                    1. Europe
                                                                                                                                      1. The Middle East and Africa
                                                                                                                                        1. Latin America
                                                                                                                                        2. China
                                                                                                                                          1. China Narcolepsy Therapeutics Market, By Treatment
                                                                                                                                            1. Narcolepsy with Cataplexy
                                                                                                                                              1. Narcolepsy without Cataplexy
                                                                                                                                                1. Secondary Narcolepsy
                                                                                                                                                2. China Narcolepsy Therapeutics Market, By Product
                                                                                                                                                  1. Central Nervous System Stimulants
                                                                                                                                                    1. Sodium Oxybate
                                                                                                                                                      1. Selective Serotonin Reuptake Inhibitor
                                                                                                                                                        1. Tricyclic Antidepressants
                                                                                                                                                          1. Others
                                                                                                                                                          2. China Narcolepsy Therapeutics Market, By Region
                                                                                                                                                            1. North America
                                                                                                                                                              1. Asia-Pacific
                                                                                                                                                                1. Europe
                                                                                                                                                                  1. The Middle East and Africa
                                                                                                                                                                    1. Latin America
                                                                                                                                                                  2. Korea
                                                                                                                                                                  3. Japan
                                                                                                                                                                  4. India
                                                                                                                                                                  5. Australia
                                                                                                                                                                  6. Taiwan
                                                                                                                                                                  7. South East Asia
                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                  1. Middle East and Africa Narcolepsy Therapeutics Market, By Treatment
                                                                                                                                                                    1. Narcolepsy with Cataplexy
                                                                                                                                                                      1. Narcolepsy without Cataplexy
                                                                                                                                                                        1. Secondary Narcolepsy
                                                                                                                                                                        2. Middle East and Africa Narcolepsy Therapeutics Market, By Product
                                                                                                                                                                          1. Central Nervous System Stimulants
                                                                                                                                                                            1. Sodium Oxybate
                                                                                                                                                                              1. Selective Serotonin Reuptake Inhibitor
                                                                                                                                                                                1. Tricyclic Antidepressants
                                                                                                                                                                                  1. Others
                                                                                                                                                                                  2. Middle East and Africa Narcolepsy Therapeutics Market, By Region
                                                                                                                                                                                    1. North America
                                                                                                                                                                                      1. Asia-Pacific
                                                                                                                                                                                        1. Europe
                                                                                                                                                                                          1. The Middle East and Africa
                                                                                                                                                                                            1. Latin America
                                                                                                                                                                                            2. UAE
                                                                                                                                                                                              1. UAE Narcolepsy Therapeutics Market, By Treatment
                                                                                                                                                                                                1. Narcolepsy with Cataplexy
                                                                                                                                                                                                  1. Narcolepsy without Cataplexy
                                                                                                                                                                                                    1. Secondary Narcolepsy
                                                                                                                                                                                                    2. UAE Narcolepsy Therapeutics Market, By Product
                                                                                                                                                                                                      1. Central Nervous System Stimulants
                                                                                                                                                                                                        1. Sodium Oxybate
                                                                                                                                                                                                          1. Selective Serotonin Reuptake Inhibitor
                                                                                                                                                                                                            1. Tricyclic Antidepressants
                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                              2. UAE Narcolepsy Therapeutics Market, By Region
                                                                                                                                                                                                                1. North America
                                                                                                                                                                                                                  1. Asia-Pacific
                                                                                                                                                                                                                    1. Europe
                                                                                                                                                                                                                      1. The Middle East and Africa
                                                                                                                                                                                                                        1. Latin America
                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                      1. LATAM Narcolepsy Therapeutics Market, By Treatment
                                                                                                                                                                                                                        1. Narcolepsy with Cataplexy
                                                                                                                                                                                                                          1. Narcolepsy without Cataplexy
                                                                                                                                                                                                                            1. Secondary Narcolepsy
                                                                                                                                                                                                                            2. LATAM Narcolepsy Therapeutics Market, By Product
                                                                                                                                                                                                                              1. Central Nervous System Stimulants
                                                                                                                                                                                                                                1. Sodium Oxybate
                                                                                                                                                                                                                                  1. Selective Serotonin Reuptake Inhibitor
                                                                                                                                                                                                                                    1. Tricyclic Antidepressants
                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                      2. LATAM Narcolepsy Therapeutics Market, By Region
                                                                                                                                                                                                                                        1. North America
                                                                                                                                                                                                                                          1. Asia-Pacific
                                                                                                                                                                                                                                            1. Europe
                                                                                                                                                                                                                                              1. The Middle East and Africa
                                                                                                                                                                                                                                                1. Latin America
                                                                                                                                                                                                                                                2. Brazil
                                                                                                                                                                                                                                                  1. Brazil Narcolepsy Therapeutics Market, By Treatment
                                                                                                                                                                                                                                                    1. Narcolepsy with Cataplexy
                                                                                                                                                                                                                                                      1. Narcolepsy without Cataplexy
                                                                                                                                                                                                                                                        1. Secondary Narcolepsy
                                                                                                                                                                                                                                                        2. Brazil Narcolepsy Therapeutics Market, By Product
                                                                                                                                                                                                                                                          1. Central Nervous System Stimulants
                                                                                                                                                                                                                                                            1. Sodium Oxybate
                                                                                                                                                                                                                                                              1. Selective Serotonin Reuptake Inhibitor
                                                                                                                                                                                                                                                                1. Tricyclic Antidepressants
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. Brazil Narcolepsy Therapeutics Market, By Region
                                                                                                                                                                                                                                                                    1. North America
                                                                                                                                                                                                                                                                      1. Asia-Pacific
                                                                                                                                                                                                                                                                        1. Europe
                                                                                                                                                                                                                                                                          1. The Middle East and Africa
                                                                                                                                                                                                                                                                            1. Latin America
                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                      • Permission to print the report


                                                                                                                                                                                                                                                                      We are featured on :